Literature DB >> 9831596

DNA methods should be used to detect Chlamydia trachomatis.

D Taylor-Robinson, A J Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9831596      PMCID： PMC1114354          DOI： 10.1136/bmj.317.7171.1525

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Screening for Chlamydia trachomatis. The case for screening is made, but much detail remains to be worked out.

Authors:  F Boag; F Kelly
Journal:  BMJ       Date:  1998-05-16

2.  Provision of diagnostic services for genital chlamydial infection in genitourinary medicine clinics: England and Wales 1996.

Authors:  I Simms; M A Catchpole; A J Robinson; C Laas
Journal:  Genitourin Med       Date:  1997-04

3.  Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.

Authors:  M R Howell; T C Quinn; W Brathwaite; C A Gaydos
Journal:  Sex Transm Dis       Date:  1998-02       Impact factor: 2.830

4.  Quantification of Chlamydia trachomatis in cervical and urine specimens from women attending a genitourinary medicine clinic: implications for screening strategies.

Authors:  B J Thomas; T Pierpoint; D Taylor-Robinson; A M Renton
Journal:  Int J STD AIDS       Date:  1998-08       Impact factor: 1.359
  4 in total
  2 in total

1.  Widening screening to detect Chlamydia trachomatis is more important than using DNA methods.

Authors:  A Herring; O Caul; I Paul; P Horner
Journal:  BMJ       Date:  1999-05-22

2.  Combined cervical swab and urine specimens for PCR diagnosis of genital Chlamydia trachomatis infection.

Authors:  M H Wilcox; M T Reynolds; C M Hoy; J Brayson
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.